Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-17-000541
Filing Date
2017-06-05
Accepted
2017-06-05 16:15:52
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 a70909_sc13g.htm SC 13G 102941
2 JOINT FILING AGREEMENT exhibit1.htm EX-99.1 12118
  Complete submission text file 0000929638-17-000541.txt   116683
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LLC (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 17891327
SIC: 2834 Pharmaceutical Preparations